These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine. Hyyppä MT; Långvik VA; Rinne UK J Neural Transm; 1978; 42(2):151-7. PubMed ID: 650205 [TBL] [Abstract][Full Text] [Related]
3. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man. Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143 [TBL] [Abstract][Full Text] [Related]
4. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients. Cusimano G; Capriani C; Bonifati V; Meco G Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236 [TBL] [Abstract][Full Text] [Related]
5. Effect of bromocriptine on serum hormones in acromegaly. Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186 [TBL] [Abstract][Full Text] [Related]
6. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly. Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344 [TBL] [Abstract][Full Text] [Related]
7. Thyrotropin, prolactin and growth hormone response to synthetic thyrotropin-releasing hormone in newborn infants. Delitala G; Meloni T; Masala A; Corti R Biol Neonate; 1978; 33(5-6):236-9. PubMed ID: 99181 [TBL] [Abstract][Full Text] [Related]
8. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly. Hanew K; Sasaki A; Mouri T; Yoshinaga K Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756 [No Abstract] [Full Text] [Related]
10. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas. Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021 [TBL] [Abstract][Full Text] [Related]
11. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly. Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686 [TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy. Popovic V; Simic M; Ilic L; Micic D; Damjanovic S; Djurovic M; Obradovic S; Dieguez C; Casanueva F Clin Endocrinol (Oxf); 1998 Jan; 48(1):103-8. PubMed ID: 9509075 [TBL] [Abstract][Full Text] [Related]
18. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH. Jeppsson S; Nilsson KO; Rannevik G; Wide L Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858 [TBL] [Abstract][Full Text] [Related]
19. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly]. Gasińska T; Nowak S Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814 [TBL] [Abstract][Full Text] [Related]
20. Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients. Harrower AD Postgrad Med J; 1980 Jul; 56(657):481-4. PubMed ID: 6777767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]